<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000562550"><TermName>anti-CD22 immunotoxin CAT-8015</TermName><TermPronunciation>(AN-tee … IH-myoo-noh-TOK-sin …)</TermPronunciation><TermDefinition><DefinitionText>A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD22 immunotoxin CAT-8015 is made in the laboratory. It binds to CD22, a protein on the surface of normal B cells and B-cell tumors, and kills the cells. Also called CAT-8015.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000721019" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anti-CD22 immunotoxin CAT-8015&quot;" language="en" id="_3"/><MediaLink ref="CDR0000721020" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inmunotoxina CAT-8015 anti-CD22&quot;" language="es" id="_4"/><SpanishTermName>inmunotoxina CAT-8015 anti-CD22</SpanishTermName><SpanishTermDefinition><DefinitionText>Anticuerpo monoclonal unido a una sustancia tóxica. Está en estudio para el tratamiento de algunos tipos de cáncer de células B. La inmunotoxina CAT-8015 anti-CD22 se produce en el laboratorio. Se une a la CD22, una proteína de la superficie de las células B normales y de las células B tumorales y destruye las células. También se llama CAT-8015.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-08-20</DateFirstPublished></GlossaryTerm>
